Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients

In glioblastoma multiforme (GBM), both temozolomide (TMZ) and cisplatin are very active at various toxic levels. Previous studies demonstrated that cisplatin with the standard regimen of TMZ is active in patients suffering from recurrent GBM, generating a moderate level of toxicity. Also, continuous...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu, Kong, Xiangyi, Guo, Yi, Wang, Renzhi, Ma, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348180/
https://www.ncbi.nlm.nih.gov/pubmed/28272232
http://dx.doi.org/10.1097/MD.0000000000006261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348180/
https://www.ncbi.nlm.nih.gov/pubmed/28272232
http://dx.doi.org/10.1097/MD.0000000000006261

Ejemplares similares